JUNE 20216JUNE - 14 - 2021, volume 05 - Issue 06 (ISSN 2691-4093) Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerChris LynnSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.comEmailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com Copyright © 2021 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comThe rising number of neurological diseases in the current time is driving every country and concerned regulatory bodies to strengthen their research and reinvent the necessary treatment processes from the ground up. A proof would be the huge number of neurology devices being approved by FDA, PMDA, Japan's Ministry of Health, Labour and Welfare, European Medicines Agency (EMA), and Australian Government's Therapeutic Goods Administration (TGA) since last year. In January 2020, Medtronic received CE mark approval for their Percept PC neurostimulator DBS system with BrainSense technology for the treatment of Parkinson's disease. Around the same time, Helius Medical Technologies has also received approval from Health Canada to commercialize the PoNS Device. This device is currently being used for the treatment and management of multiple sclerosis (MS). And all these innovative neurology devices are showing promising effects on curing diseases that affect the activity of the central nervous system. Adjacently, there are many new neurology device manufacturers currently entering this arena with the vision of making a positive impact on the neurological care delivery.In this edition of MedTech Outlook, we bring you the story of some of the most promising neurology device providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best neurology device provider according to your requirements.Let us know your thoughts!Changing Paradigm of Neurological Disease TreatmentSarah FernandesEDITORIAL
< Page 5 | Page 7 >